<HTML>
<HEAD>
<TITLE>AOD Thesaurus Annotated Hierarchy: biomedicine EF EG16.2</TITLE>
<META
Name="Description"sA Guide to Concepts and Terminology in Substance Abuse and Addiction">
</META>
<META
Name="Keywords"
Content="classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept">
</META>
</HEAD>
<body bgcolor="#FFFFFF">
<CENTER><B><BIG>AOD Thesaurus.&nbsp;&nbsp;Annotated Hierarchy.&nbsp;&nbsp;biomedicine.&nbsp;&nbsp;EF - EG16.2</BIG></B></Center>
<CENTER><A HREF="aodob.htm#E">b-out</A>&nbsp;&nbsp;To Broad Outline&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#EF">d-out</A>&nbsp;&nbsp;To Detailed Outline&nbsp;&nbsp;&nbsp;&nbsp;
<A HREF="aodhqe.htm">qh</A>&nbsp;&nbsp;To Quick Hierarchy</CENTER>
<CENTER><A HREF="aodhned.htm">Previous</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm">Next</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodwsrch.htm">Search</A></CENTER><BR><BR>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF"><B><BIG>EF</BIG></B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B><BIG>route of administration</BIG></B>&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#EF"><SMALL>d-out</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The way in which a substance reaches its site of action in the body.  The substance may be administered for therapeutic or psychoactive effects--possibly as part of a human or animal experiment--by a
   third party or by the subjects themselves, or the subject may be exposed to the substance through the environment or in utero. 
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The major distinction between routes of administration is not the site where a substance is introduced or applied to the body, or even the way it is
   introduced or applied, but whether it takes effect merely in the local area where it is applied or whether it reaches its destination through systemic circulation.  A further criterion is whether
   the drug reaches systemic circulation directly or whether it first passes through the liver, where it may be metabolized or excreted (first-pass effect in enteral administration).  (Note: Drugs
   administered into the systemic circulation by any route, excluding intra-arterial injection, are subject to possible first-pass elimination in the lung prior to distribution to the rest of the
   body.) 
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whether administration of a drug results in local or systemic action depends not only on the site and method of administration but also on the properties of
   the drug; sometimes the drug has both local and systemic action.  This is particularly true for application to a mucous membrane, which may be intended for a local action but also may include,
   sometimes unwanted, systemic action.  Furthermore, a drug may be absorbed at several sites (e.g., the mouth and the lung, the rectum and the intestine) in various proportions.  To account at least
   partially for the very complex phenomena of the absorption of drugs into the body, the following classification uses two dimensions, or facets: by scope of drug action and by method or body site of
   administration.  To index the route of administration completely, use at least one descriptor from each facet. 
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Combine with *+EE20 chemical exposure* <A HREF="aodhqe.htm#EE20"><SMALL>qh</SMALL></A> <A HREF="aodhned.htm#EE20"><SMALL>ah</SMALL></A> to indicate accidental
   or inadvertent contact with a substance.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> medication route </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> method of delivery of drugs or food </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> mode of substance administration </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> route of drug application </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> route of drug entry </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> route of exposure </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EE12e pharmacokinetics &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+AA2e AOD use &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AA2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AA2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BS AOD substance by route of administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BS"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BS"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EE12.2e drug absorption &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE12-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE14.4.8 drug effect by location &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE20e chemical exposure &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE20"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+HK2.10.2.2.4 nicotine replacement &nbsp;&nbsp;&nbsp;<A HREF="aodhqhj.htm#HK2-10-2-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnhj.htm#HK2-10-2-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+HRe drug therapy &nbsp;&nbsp;&nbsp;<A HREF="aodhqhj.htm#HR"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnhj.htm#HR"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>OC2 drug paraphernalia &nbsp;&nbsp;&nbsp;<A HREF="aodhqo.htm#OC2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhno.htm#OC2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF2"><B>EF2</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>route of administration by scope of drug action</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
<TR><TD WIDTH="25%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Use at least one of the narrower descriptors and combine it with the appropriate descriptor from *+EF4 route of administration by method or body site* <A HREF="aodhqe.htm#EF4"><SMALL>qh</SMALL></A>
   <A HREF="aodhnef.htm#EF4"><SMALL>ah</SMALL></A>.  If specific information is not available, use this broad descriptor.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF2-2">EF2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>topical and local administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
<TR><TD WIDTH="27%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The application of a substance to a localized area, chiefly for local effects at this site.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>HU4.2 local anesthesia &nbsp;&nbsp;&nbsp;<A HREF="aodhqhj.htm#HU4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnhj.htm#HU4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>EE14.4.8.2 local drug effect &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>GH10.2 chemical injury &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GH10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngf.htm#GH10-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF2-2-2">EF2.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>topical administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF2-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The application of a substance on the surface of the skin or on a mucous membrane (including the gastrointestinal membrane) so that the substance will take effect on the surface or on a localized
   layer under the surface.  For example, for the administration of a decongestant spray, use *EF2.2.2 topical administration* <A HREF="aodhqe.htm#EF2-2-2"><SMALL>qh</SMALL></A> <A
   HREF="aodhnef.htm#EF2-2-2"><SMALL>ah</SMALL></A> combined with *EF4.4.4.4 nasal administration* <A HREF="aodhqe.htm#EF4-4-4-4"><SMALL>qh</SMALL></A> <A
   HREF="aodhnef.htm#EF4-4-4-4"><SMALL>ah</SMALL></A>.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> topical application </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF2-2-4">EF2.2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>local drug administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF2-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
<TR><TD WIDTH="29%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The introduction of a substance into a localized area of the skin or other tissue, for example, through injection.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>EF4.6.4 intra-arterial injection &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-6-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EF4.6.8 intracutaneous injection &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-6-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EF4.6.16 CNS injection &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-6-16"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF2-4">EF2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>systemic administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
<TR><TD WIDTH="27%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The introduction of a substance into systemic circulation so that it is carried to the site of effect.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+EF4.6.2e intravenous injection &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EF4.6.10 administration through skin implant &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-6-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>HU4.4 general anesthesia &nbsp;&nbsp;&nbsp;<A HREF="aodhqhj.htm#HU4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnhj.htm#HU4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>EE14.4.8.4 systemic drug effect &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE14-4-8-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE14-4-8-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EF4.4.4 inhalation, smoking, sniffing &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+GH10.4 chemical poisoning &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GH10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngf.htm#GH10-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4"><B>EF4</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>route of administration by method or body site</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
<TR><TD WIDTH="25%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Because in many cases a drug can have local or systemic effects regardless of the method or body site of administration, any of these descriptors should be combined with the appropriate descriptor
   from *+EF2 route of administration by scope of drug action* <A HREF="aodhqe.htm#EF2"><SMALL>qh</SMALL></A> <A HREF="aodhnef.htm#EF2"><SMALL>ah</SMALL></A>.  Where appropriate, a route of
   administration can be specified further by combining it with a descriptor from *+X body part* <A HREF="aodhqx.htm#X"><SMALL>qh</SMALL></A> <A HREF="aodhnx.htm#X"><SMALL>ah</SMALL></A>, for example,
   *EF4.6.14 intramuscular injection* <A HREF="aodhqe.htm#EF4-6-14"><SMALL>qh</SMALL></A> <A HREF="aodhnef.htm#EF4-6-14"><SMALL>ah</SMALL></A> combined with *+XD8.4 leg* <A
   HREF="aodhqx.htm#XD8-4"><SMALL>qh</SMALL></A> <A HREF="aodhnx.htm#XD8-4"><SMALL>ah</SMALL></A>. 
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The classification given here, especially the grouping of a number of routes under the heading *+EF4.4 mucosal administration* <A
   HREF="aodhqe.htm#EF4-4"><SMALL>qh</SMALL></A> <A HREF="aodhnef.htm#EF4-4"><SMALL>ah</SMALL></A>, follows, in part, Taber's Cyclopedic Medical Dictionary, 17th ed., 1993.  Both *+EF4.2 enteral
   administration* <A HREF="aodhqe.htm#EF4-2"><SMALL>qh</SMALL></A> <A HREF="aodhnef.htm#EF4-2"><SMALL>ah</SMALL></A> and *+EF4.4 mucosal administration* <A
   HREF="aodhqe.htm#EF4-4"><SMALL>qh</SMALL></A> <A HREF="aodhnef.htm#EF4-4"><SMALL>ah</SMALL></A> leave body membranes intact, whereas *+EF4.6 parenteral administration* <A
   HREF="aodhqe.htm#EF4-6"><SMALL>qh</SMALL></A> <A HREF="aodhnef.htm#EF4-6"><SMALL>ah</SMALL></A> introduces substances into the body by mechanically penetrating a membrane.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EF2 route of administration by scope of drug action &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-2">EF4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>enteral administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The administration of a substance by way of the gastrointestinal tract (i.e., stomach and intestine), usually for systemic action.  A drug that is absorbed from the stomach or intestine first must
   pass through the liver; therefore, some of the active drug will be inactivated or diverted before it can reach systemic circulation.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> nonparenteral administration </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-2-2">EF4.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>oral enteral administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
<TR><TD WIDTH="29%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The introduction of a substance into the gastrointestinal tract by way of the mouth, usually for systemic action.  The drug will be exposed to the gastric environment, which transforms some drugs. 
   For administration by way of absorption through the oral mucosa, use *+EF4.4.6 oral mucosal administration* <A HREF="aodhqe.htm#EF4-4-6"><SMALL>qh</SMALL></A> <A
   HREF="aodhnef.htm#EF4-4-6"><SMALL>ah</SMALL></A> or a narrower term.  The term "oral administration," or simply "orally," often is used in the narrower meaning of "oral enteral administration" as
   defined here.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> drug ingestion </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> per os administration </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> PO administration </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EF4.10e oral administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EA24.8e nutrient intake &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EA24-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EA24-8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-2-4">EF4.2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>rectal enteral administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
<TR><TD WIDTH="29%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The introduction of a substance into the gastrointestinal tract by way of the rectum, usually for systemic action.  For application by way of absorption through the rectal mucosa, use *EF4.4.8 rectal
   mucosal administration* <A HREF="aodhqe.htm#EF4-4-8"><SMALL>qh</SMALL></A> <A HREF="aodhnef.htm#EF4-4-8"><SMALL>ah</SMALL></A>.  If both ways of absorption apply or if in doubt, use the broader
   term *+EF4.12 rectal administration* <A HREF="aodhqe.htm#EF4-12"><SMALL>qh</SMALL></A> <A HREF="aodhnef.htm#EF4-12"><SMALL>ah</SMALL></A>.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EF4.12 rectal administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-12"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-4">EF4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>mucosal administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
<TR><TD WIDTH="27%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The administration of a substance by way of application to a mucous membrane (other than the gastrointestinal tract), the pulmonary epithelium, or the skin.  The drug action may be topical/local,
   systemic (through absorption by a mucous membrane or other surface), or a combination of both.  The classification is based primarily on the site where the absorption takes place, not on the site
   where the substance enters the body.  Thus, in pulmonary administration, the gas could be inhaled through the mouth or through the nose.  Unless implied by the specific narrower descriptor, combine
   with the appropriate descriptor from *+X body part* <A HREF="aodhqx.htm#X"><SMALL>qh</SMALL></A> <A HREF="aodhnx.htm#X"><SMALL>ah</SMALL></A> to indicate the site of the application.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>EF4.6.6e intraperitoneal administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>XQ4.2.18 vagina &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XQ4-2-18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XQ4-2-18"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XV6.2e eye &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XV6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxv.htm#XV6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-4-2">EF4.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>transdermal administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.  ETOH descriptor 2000.
  </TD></TR>
<TR><TD WIDTH="29%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Administration of a substance by way of absorption through the skin, usually for systemic action.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> cutaneous application </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EF4.8 skin administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XH2e skin &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XH2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XH2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>EF4.6.10 administration through skin implant &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-6-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EF4.6.12 subcutaneous injection &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-6-12"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-4-2-2">EF4.4.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>skin patch&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">RT</TD><TD>+BDe tobacco in any form &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BD"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BD"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-4-2-4">EF4.4.2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>iontophoresis&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="31%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Therapeutic introduction of ions of soluble salts into tissues by means of electric current. Iontophoresis can be used for local and systemic drug delivery without the complications of injection.  In
   medical literature it is commonly used to indicate the process of increasing the penetration of drugs into surface tissues by the application of electric current. (It has nothing to do with ion
   exchange, air ionization nor phonophoresis, none of which requires current.)  
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> galvanoionization </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> iontotherapy </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> medical ionization </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+CQ12.22.6e electrophoresis &nbsp;&nbsp;&nbsp;<A HREF="aodhqc.htm#CQ12-22-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnc.htm#CQ12-22-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+HP8.12 electrotherapy &nbsp;&nbsp;&nbsp;<A HREF="aodhqhj.htm#HP8-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnhj.htm#HP8-12"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-4-2-4-2">EF4.4.2.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>microiontopheresis&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-2-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-4-4">EF4.4.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>inhalation, smoking, sniffing&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
<TR><TD WIDTH="29%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The administration of a substance in the form of a gas, aerosol (including smoke), or fine powder by way of the nose, lung, or mouth. 
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Use this descriptor only if specific information is not available; otherwise, use all applicable narrower descriptors.  Examples: If a drug is inhaled through
   the mouth or the nose but is absorbed mostly in the lung, use *+EF4.4.4.6 pulmonary administration* <A HREF="aodhqe.htm#EF4-4-4-6"><SMALL>qh</SMALL></A> <A
   HREF="aodhnef.htm#EF4-4-4-6"><SMALL>ah</SMALL></A>; if a drug is inhaled through the nose and is absorbed in significant proportions in both the nose and the lung, use both *EF4.4.4.4 nasal
   administration* <A HREF="aodhqe.htm#EF4-4-4-4"><SMALL>qh</SMALL></A> <A HREF="aodhnef.htm#EF4-4-4-4"><SMALL>ah</SMALL></A> and *+EF4.4.4.6 pulmonary administration* <A
   HREF="aodhqe.htm#EF4-4-4-6"><SMALL>qh</SMALL></A> <A HREF="aodhnef.htm#EF4-4-4-6"><SMALL>ah</SMALL></A>.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> insufflation </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+BGe volatile inhalant &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BG"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BG"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EF2.4 systemic administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-4-4-2">EF4.4.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>smoking&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
<TR><TD WIDTH="31%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>"Smoking" often is used to mean "smoking tobacco."  However, here the descriptor smoking refers to smoking any substance.  To index tobacco smoking, combine with *+BD tobacco in any form* <A
   HREF="aodhqb.htm#BD"><SMALL>qh</SMALL></A> <A HREF="aodhnb.htm#BD"><SMALL>ah</SMALL></A> or the appropriate narrower descriptor.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>OD2.4 freebasing &nbsp;&nbsp;&nbsp;<A HREF="aodhqo.htm#OD2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhno.htm#OD2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EF4.10e oral administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+BDe tobacco in any form &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BD"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BD"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BD6 tobacco smoke &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BD6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BD6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BEe marijuana in any form &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BE"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BE"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BS4e inhaled substance &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BS4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BS4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE20.2 passive inhalation &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE20-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-4-4-2-2">EF4.4.4.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>smoking without inhalation&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-4-4-2-4">EF4.4.4.2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>smoking with inhalation&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-4-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EF4.4.4.6e pulmonary administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-4-4-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-4-4-4">EF4.4.4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nasal administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
<TR><TD WIDTH="31%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The administration of a substance by way of the nose, often with systemic action due to absorption through the nasal mucosa.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> drug blowing </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> drug sniffing </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> drug snorting </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+XK2.2.2 nasal membrane &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XK2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XK2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>BK4.4 cocaine powder &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BK4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BK4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+BS4e inhaled substance &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BS4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BS4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EF2.2.2 topical administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>XK2.4e pharynx &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XK2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XK2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-4-4-6">EF4.4.4.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pulmonary administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-4-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
<TR><TD WIDTH="31%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The administration of a substance in the form of a gas or aerosol through inhalation into the lung, often with systemic action due to absorption through the pulmonary epithelium and mucous membranes
   of the respiratory tract.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> drug inhalation (nose) </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> huffing </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>EF4.4.4.2.4 smoking with inhalation &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-4-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-4-4-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+XK4e lung &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XK4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XK4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-4-4-6-2">EF4.4.4.6.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nicotine inhaler&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-4-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BDe tobacco in any form &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BD"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BD"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+HK2.10.2.2.4 nicotine replacement &nbsp;&nbsp;&nbsp;<A HREF="aodhqhj.htm#HK2-10-2-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnhj.htm#HK2-10-2-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-4-4-6-4">EF4.4.4.6.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nicotine spray&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-4-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="33%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+BDe tobacco in any form &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BD"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BD"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-4-6">EF4.4.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>oral mucosal administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
<TR><TD WIDTH="29%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The administration of a substance to the oral mucosa, often with systemic action due to absorption.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>EN2 chewing &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EN2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm#EN2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EF4.10e oral administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>BD4.6.2 chewing tobacco &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BD4-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BD4-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>BJ4.4.4e betel nut &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BJ4-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BJ4-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EF4.2.2 oral enteral administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-4-6-2">EF4.4.6.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>buccal administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
<TR><TD WIDTH="31%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The administration of a substance to the mucosa on the inside of the cheek or the back of the mouth.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-4-6-4">EF4.4.6.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>sublingual administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The administration of a substance to the mucosa of the tongue and under the tongue.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+XL2.4 tongue &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XL2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XL2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>BD4.6.2 chewing tobacco &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BD4-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BD4-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>BJ4.4.4e betel nut &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BJ4-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BJ4-4-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-4-8">EF4.4.8</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>rectal mucosal administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EF4.12 rectal administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>EF4.2.4 rectal enteral administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-6">EF4.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>parenteral administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>The administration of a substance through injection or infusion.  Usually the drug action is systemic, but in some cases, it is confined to a local area.  Combine with the appropriate descriptor from
   *+X body part* <A HREF="aodhqx.htm#X"><SMALL>qh</SMALL></A> <A HREF="aodhnx.htm#X"><SMALL>ah</SMALL></A> to indicate the site of the injection.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> infusion </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> injection </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+EE20.6e prenatal chemical exposure &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE20-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE20-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>BS2e injected substance &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BS2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BS2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-6-2">EF4.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>intravenous injection&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> IV injection </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> mainlining </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> shooting up </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EF2.4 systemic administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XJ6.4e vein &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XJ6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XJ6-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+BS AOD substance by route of administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BS"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BS"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>BS2e injected substance &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BS2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnbg.htm#BS2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>TL4.10.4e intravenous drug user &nbsp;&nbsp;&nbsp;<A HREF="aodhqt.htm#TL4-10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnt.htm#TL4-10-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-6-2-2">EF4.6.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>intravenous infusion&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-6-4">EF4.6.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>intra-arterial injection&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Occasionally a drug is injected directly into an artery to localize its effect to a particular tissue or organ.  However, this practice usually has dubious therapeutic value.  Diagnostic agents
   sometimes are administered by this route.  Intra-arterial injection requires great care and should be reserved for experts.  The first-pass and cleansing effects of the lung are not available when
   drugs are given by this route.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EF2.2.4 local drug administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF2-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF2-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XJ6.2e artery &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XJ6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XJ6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-6-6">EF4.6.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>intraperitoneal administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
<TR><TD WIDTH="29%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Injection of a substance into the peritoneum, where it is absorbed by the lining.  The substance is subject to first pass through the liver.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> intraperitoneal infusion </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> intraperitoneal injection </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+XD6.4.4e peritoneum &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XD6-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#XD6-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EF4.4e mucosal administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-6-8">EF4.6.8</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>intracutaneous injection&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> endermic injection </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> intradermal injection </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EF2.2.4 local drug administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF2-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF2-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EF4.8 skin administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XH2e skin &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XH2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XH2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-6-10">EF4.6.10</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>administration through skin implant&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EF2.4 systemic administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EF4.8 skin administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XH2e skin &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XH2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XH2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EF4.4.2e transdermal administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-6-12">EF4.6.12</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>subcutaneous injection&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">ST</TD><TD> hypodermic injection </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> skin popping </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> subcutaneous application </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EF4.8 skin administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XH2e skin &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XH2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XH2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EF4.4.2e transdermal administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-6-14">EF4.6.14</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>intramuscular injection&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">ST</TD><TD> IM injection </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EF4 route of administration by method or body site &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-6-16">EF4.6.16</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>CNS injection&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-16"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EF2.2.4 local drug administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF2-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF2-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XZe central nervous system &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XZ"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxv.htm#XZ"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-6-16-2">EF4.6.16.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>intrathecal injection&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-16-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Injection of drugs directly into the spinal subarachnoid space in order to achieve local, rapid effects on the meninges or cerebrospinal axis.  Used in spinal anesthesia or acute CNS infections in
   order to bypass the *XZ2.2.4 blood-brain barrier* <A HREF="aodhqx.htm#XZ2-2-4"><SMALL>qh</SMALL></A> <A HREF="aodhnxv.htm#XZ2-2-4"><SMALL>ah</SMALL></A>.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-8">EF4.8</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>skin administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD>+EF4.4.2e transdermal administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EF4.6.8 intracutaneous injection &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-6-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EF4.6.10 administration through skin implant &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-6-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EF4.6.12 subcutaneous injection &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-6-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-6-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+XH2e skin &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XH2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XH2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>HF20.22 skin test &nbsp;&nbsp;&nbsp;<A HREF="aodhqha.htm#HF20-22"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnha.htm#HF20-22"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-10">EF4.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>oral administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>EF4.2.2 oral enteral administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EF4.4.4.2e smoking &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EF4.4.6 oral mucosal administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+XL2e mouth &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XL2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XL2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF4-12">EF4.12</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>rectal administration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>With rectal administration that is not purely topical, some proportion of the drug may be absorbed directly through the rectal mucosa and not be subject to first pass through the liver, whereas
   another portion may pass into the intestine and be absorbed from there.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>EF4.2.4 rectal enteral administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EF4.4.8 rectal mucosal administration &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF4-4-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EF4-4-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+XM2.4.10e rectum &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XM2-4-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XM2-4-10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF6"><B>EF6</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>drug administration by self versus others</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
<TR><TD WIDTH="25%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>This aspect often is not indexed, except for *EF6.2 self-administration of drugs* <A HREF="aodhqe.htm#EF6-2"><SMALL>qh</SMALL></A> <A HREF="aodhnef.htm#EF6-2"><SMALL>ah</SMALL></A> by animals in
   animal studies or self use of a method of administration normally performed by others, such as injection.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF6-2">EF6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>self-administration of drugs&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EF6-4">EF6.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>drug administration by others&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EF6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 </TABLE>
<BR>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG"><B><BIG>EG</BIG></B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B><BIG>cell function</BIG></B>&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#EG"><SMALL>d-out</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">BT</TD><TD>+EAe general life processes &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EA"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EA"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XAe cell and cell structure &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XA"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#XA"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG2"><B>EG2</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>cell growth and differentiation</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">ST</TD><TD> cell development </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EDe growth and development &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ED4.10.2.4 organogenesis &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-10-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ED6.4.4 biological involution &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED6-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED6-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ET4.6.4 lymphocyte activation &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ET4-6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm#ET4-6-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG2-2">EG2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>cell division&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">ST</TD><TD> cell growth </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> cell proliferation </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> cell replication </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG2-2-2">EG2.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>cell cycle&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG2-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">RT</TD><TD>+ED6e biological life cycle &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG2-2-4">EG2.2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>mitosis&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG2-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">RT</TD><TD>+XA2.2e cell nucleus &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XA2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#XA2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG2-2-6">EG2.2.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>meiosis&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG2-2-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">RT</TD><TD>+ES4.2 gametogenesis &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ES4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm#ES4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XA2.2e cell nucleus &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XA2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#XA2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG2-4">EG2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>cell differentiation&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A process by which cells become specialized in structure and function
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG2-6">EG2.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>cell life cycle&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG2-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG2-6-6">EG2.6.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>cytolysis&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG2-6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
<TR><TD WIDTH="29%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Destruction or breakdown of the living cell, primarily by disintegration of the outer membrane.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> cell death </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+GG14.6e necrosis &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GG14-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngf.htm#GG14-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>ED6.6 biological death &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ET4e immune function &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ET4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm#ET4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG2-6-6-2">EG2.6.6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>apoptosis&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG2-6-6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="31%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>A series of chemical reactions within a cell that are induced by various events and which result in the cell's death.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG2-8">EG2.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>cell migration&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG2-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
<TR><TD WIDTH="27%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The movement of maturing cells to their ultimate locations so that they can serve a specific role in the overall coordinated activity of an organ.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> cellular migration </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ED4.4.2 morphogenesis &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ED4.10.2.4 organogenesis &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-10-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-10-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ET4.6.4 lymphocyte activation &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ET4-6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm#ET4-6-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG2-8-2">EG2.8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>chemotaxis&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG2-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> chemiotaxis </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> chemotropism </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EA14 biological movement &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EA14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EA14"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XS2.10e leukocytes &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XS2-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxr.htm#XS2-10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG6"><B>EG6</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>cell-cell interaction</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">RT</TD><TD>+ED4.4.2 morphogenesis &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EG10e cell signaling &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG6-6">EG6.6</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>cell aggregation&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">BT</TD><TD>+ED4.4.2 morphogenesis &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ED4-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#ED4-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>ET2.4.2.2e platelet aggregation &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ET2-4-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm#ET2-4-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG8"><B>EG8</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>cell electrophysiology</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Use this descriptor for general mention; more specific descriptors appear under *+EG10 cell signaling* <A HREF="aodhqe.htm#EG10"><SMALL>qh</SMALL></A> <A
   HREF="aodhnef.htm#EG10"><SMALL>ah</SMALL></A>, *EG12 signal transduction* <A HREF="aodhqe.htm#EG12"><SMALL>qh</SMALL></A> <A HREF="aodhnef.htm#EG12"><SMALL>ah</SMALL></A>, *+EG14 cell membrane
   biology* <A HREF="aodhqe.htm#EG14"><SMALL>qh</SMALL></A> <A HREF="aodhnef.htm#EG14"><SMALL>ah</SMALL></A>, and *+EG16 mitochondrial biology* <A HREF="aodhqe.htm#EG16"><SMALL>qh</SMALL></A> <A
   HREF="aodhnef.htm#EG16"><SMALL>ah</SMALL></A>.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+HG22.8.6e evoked potential &nbsp;&nbsp;&nbsp;<A HREF="aodhqha.htm#HG22-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnha.htm#HG22-8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EA2e electrical life processes &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EA2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EA2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+CB26 electrical property &nbsp;&nbsp;&nbsp;<A HREF="aodhqc.htm#CB26"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnc.htm#CB26"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EG14.8.4.4e voltage gated channel &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-8-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG14-8-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EW6.4 electrical neurotransmission &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EW6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneu.htm#EW6-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+HE8e electrodiagnosis &nbsp;&nbsp;&nbsp;<A HREF="aodhqha.htm#HE8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnha.htm#HE8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG10"><B>EG10</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>cell signaling</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">NT</TD><TD>+EW6e neurotransmission &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EW6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneu.htm#EW6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EG6 cell-cell interaction &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EG8e cell electrophysiology &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EG14.2e receptor ligand binding &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG14-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YFe hormones &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YF"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YF"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YKe receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG10-2">EG10.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>electrical cell signaling&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG10-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>EW6.4 electrical neurotransmission &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EW6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneu.htm#EW6-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>EG14.8.4.4e voltage gated channel &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-8-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG14-8-4-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG10-4">EG10.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>chemical cell signaling&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG10-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 1995.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>EW6.6 chemical neurotransmission &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EW6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneu.htm#EW6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YFe hormones &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YF"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YF"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YKe receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG12"><B>EG12</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>signal transduction</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">ST</TD><TD> sensory transduction </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EV2e sensation &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EV2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneu.htm#EV2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EG8e cell electrophysiology &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EVe sensory system function &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EV"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneu.htm#EV"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG14"><B>EG14</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>cell membrane biology</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">RT</TD><TD>+EC2e biological transport &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EC2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EC2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EG8e cell electrophysiology &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XA2.12e cell membrane &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XA2-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#XA2-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YKe receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG14-2">EG14.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>receptor ligand binding&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Please note that documents will often discuss the concept of receptor binding without explicitly mentioning ligands.  Receptor binding always involves ligands.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> receptor binding </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> receptor coupling </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> receptor ligand affinity </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>CK2.4e structure activity relationship &nbsp;&nbsp;&nbsp;<A HREF="aodhqc.htm#CK2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnc.htm#CK2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EE12.4.4e drug binding &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE12-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE12-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EG10e cell signaling &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YKe receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG14-4">EG14.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>membrane fluidity&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG14-6">EG14.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>membrane permeability&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">ST</TD><TD> membrane gating properties </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EC2.6e passive transport &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EC2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EC2-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG14-8">EG14.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>membrane channel&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>Proteins that span the cell membrane, forming pores that regulate the flow of specific charged particles into and out of the cell. Use to index documents dealing with membrane structures involved in
   transmembrane transport. 
  <BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Use *+EC2 biological transport* <A HREF="aodhqe.htm#EC2"><SMALL>qh</SMALL></A> <A HREF="aodhne.htm#EC2"><SMALL>ah</SMALL></A> or narrower terms to index
   documents containing less specific concepts.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> ion channels </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>ZO6.4.6.4e membrane transport protein &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO6-4-6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO6-4-6-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+XA2.12e cell membrane &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XA2-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#XA2-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EC2e biological transport &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EC2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EC2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EC2.10e ion transport &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EC2-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EC2-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YD8.12.2e ionophores &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YD8-12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YD8-12-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YKe receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YK6.4.4e nicotinic receptor &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK6-4-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG14-8-2">EG14.8.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nongated membrane channel&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">ST</TD><TD> nongated ion channel </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EC2.6e passive transport &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EC2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EC2-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG14-8-4">EG14.8.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>gated membrane channel&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-8-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">ST</TD><TD> gated ion channel </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG14-8-4-2">EG14.8.4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>receptor operated channel&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-8-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD><TD WIDTH="5%">ST</TD><TD> chemically gated channels </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> ligand gated ion channels </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> ROC </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YKe receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG14-8-4-4">EG14.8.4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>voltage gated channel&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-8-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> voltage activated ion channel </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> voltage gated ion channel </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EG8e cell electrophysiology &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EG10.2 electrical cell signaling &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG10-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG14-8-6">EG14.8.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>chloride channel&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-8-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">RT</TD><TD>+YK6.8e GABA receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK6-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YK10e benzodiazepine receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK10"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG14-8-8">EG14.8.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>calcium channel&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-8-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">RT</TD><TD><TT>&nbsp;</TT>YK6.10.2e NMDA receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6-10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK6-10-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG14-8-10">EG14.8.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>potassium channel&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-8-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="29%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Potassium channels play a major role in regulating membrane potential and producing membrane repolarization following transmission of nerve impulses.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG14-8-12">EG14.8.12</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>antiport&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-8-12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG14-10">EG14.10</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>endocytosis or exocytosis&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG14-10-2">EG14.10.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>endocytosis&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-10-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG14-10-2-2">EG14.10.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>phagocytosis&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-10-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> autophagy/autophagia </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ET4.6.6 antigen elimination &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#ET4-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm#ET4-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>XA2.4.10e lysosome &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XA2-4-10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#XA2-4-10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>XS2.10.2.2e neutrophilic granulocyte &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XS2-10-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxr.htm#XS2-10-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG14-10-2-4">EG14.10.2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>pinocytosis&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-10-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG14-10-4">EG14.10.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>exocytosis&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-10-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG16"><B>EG16</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>mitochondrial biology</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG16"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">RT</TD><TD>+EG8e cell electrophysiology &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>XA2.4.8e mitochondria &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XA2-4-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#XA2-4-8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="EG16-2">EG16.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>mitochondrial transport&nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG16-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD>+EB4.4e electron transfer &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EB4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EB4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+EC2e biological transport &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EC2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EC2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ZA2.4.4.6e calcium &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZA2-4-4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZA2-4-4-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
</TABLE><BR><BR>
<CENTER><A HREF="aodob.htm#E">b-out</A>&nbsp;&nbsp;To Broad Outline&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#EF">d-out</A>&nbsp;&nbsp;To Detailed Outline&nbsp;&nbsp;&nbsp;&nbsp;
<A HREF="aodhqe.htm">qh</A>&nbsp;&nbsp;To Quick Hierarchy</CENTER>
<CENTER><A HREF="aodhned.htm">Previous</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodhneh.htm">Next</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodwsrch.htm">Search</A></CENTER><P>classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept </P>
</BODY>
</HTML>
